Climate Change Data Portal
| Diversity and functioning of coastal marine biomes under siege: implication of seaweed proliferations across three oceans | |
| 项目编号 | ANR-11-EBIM-0003 |
| Madame Claude Payri | |
| 项目主持机构 | Biodiversité des écosystèmes coralliens de l'Indo-Pacifique |
| 开始日期 | 2011-10-01 |
| 结束日期 | 2014-10-01 |
| 英文摘要 | Dyspnea is a major problem in many classes of patients including ICU patients, patients with chronic lung and heart disease, and patients nearing the end of life from most causes. The armamentarium for treatment of intractable dyspnea is very limited. The only drugs proven effective in reducing dyspnea when treatment of the underlying disease has not brought relief are systemic opiates. Opiates carry many disadvantages including depression of respiration, confusion, nausea and constipation. Inhaled furosemide aerosol has shown promise in relieving dyspnea with none of these side effects. Both controlled laboratory studies and small clinical studies have produced encouraging but very variable results. Evidence suggests that furosemide works locally in the lung by sensitizing slowly adapting pulmonary stretch receptors, giving the sensory 'illusion'of larger breaths;we have previously shown that stimulation of pulmonary stretch receptors with larger ventilator- delivered breaths relieves dyspnea;the bigger the breath, the greater the relief. Two placebo-controlled laboratory human studies of aerosol furosemide (one from our lab) have shown that the response in individual subjects ranges from profound relief of air hunger to no response. Importantly, no subjects experienced worsening of air hunger, showing that the positive effect observed in many subjects is not merely measurement variability. This variation of response among subjects has resulted in experimental results that are encouraging if inconclusive. Given this variation of response in laboratory conditions, it is not surprising that overall outcomes of the few small clinical trials have varied greatly;the majority of trials have been encouraging but none has been conclusive. We hypothesize that treatment failures have been due to two factors: 1) inconsistent aerosol drug delivery and 2) failure to adjust drug dose according to individual phenotypic sensitivity to the drug. Before undertaking a large clinical trial of this promising therapy, it is necessary to discover how to make the treatment more uniformly effective. Our aim is to show that this can be achieved by: a) controlling aerosol inhalation characteristics such as aerosol particle size, inspiratory volume and flow rate, and residence time (i.e., inspiratory pause);a large body of aerosol science research demonstrates that these factors have profound effects on drug deposition. b) determining the effect of higher dose on treatment efficacy. We will perform definitive laboratory studies to determine aerosol administration protocols and dose regimens that give consistent dyspnea relief. Having optimized aerosol delivery and dose, we will perform studies aimed at translating laboratory findings into clinical practice. These studies in hospitalized patients requiring palliation for dyspnea will lead to larger scale clinical effectiveness trials. We believe this integration of laboratory and clinical studies within one grant will optimize translation of results from laboratory to patient. |
| 英文关键词 | Adverse effects;aerosolized;Aerosols;Age;Air;American;analog;Area;Back;Breathing;Characteristics;Chronic lung disease;Clinic;Clinical;Clinical effectiveness;clinical practice;Clinical Protocols;Clinical Research;Clinical Sciences;Clinical Trials;Confusion;Conscious;Constipation;cost;Deposition;design;Development;Disadvantaged;Disease;Dose;Drug Delivery Systems;Dyspnea;Effectiveness;effectiveness clinical trial;effectiveness research;end of life;Evaluation;experience;Failure (biologic function);Feedback;Funding;Furosemide;Future;Generations;Grant;Heart Diseases;Human;Hunger;Illusions;Impairment;improved;Individual;Inpatients;Laboratories;Laboratory Finding;Laboratory Study;Lead;Lung;Lung diseases;Malignant Neoplasms;Measurement;Measures;member;Mental Depression;Metered Dose Inhaler Device;Methods;minimal risk;Modeling;Morphine;Nausea;novel;Opiates;Outcome;palliation;Palliative Care;Particle Size;Patients;Pattern;Pharmaceutical Preparations;Physiological;Placebo Control;Procedures;Protocols documentation;Provider;Pulmonary Stretch Receptors;Quality of Care;randomized placebo controlled trial;receptor;Regimen;Research;residence;Respiration;response;Science;Scientist;Sensory;Shortness of Breath;Site;Source;Specificity;Stimulus;symptom management;Symptoms;Testing;Therapeutic Effect;Time;Translating;translational approach;Translational Research;Translations;treatment effect;Treatment Effectiveness;Treatment Efficacy;Treatment Failure;United States National Institutes of Health;Variant;Ventilator;Work |
| 资助机构 | FR-ANR |
| 项目经费 | 246080 |
| 项目类型 | Towards Biodiversity Management in support of Sustainable Development in Tropical and Subtropical EU (NET-BIOME 2010) 2011 |
| URL | http://www.agence-nationale-recherche.fr/en/anr-funded-project/?solr=run&tx_lwmsuivibilan_pi2%5BCODE%5D=ANR-11-EBIM-0003 |
| 国家 | FR |
| 语种 | 英语 |
| 文献类型 | 项目 |
| 条目标识符 | http://gcip.llas.ac.cn/handle/2XKMVOVA/75485 |
| 推荐引用方式 GB/T 7714 | Madame Claude Payri.Diversity and functioning of coastal marine biomes under siege: implication of seaweed proliferations across three oceans.2011. |
| 条目包含的文件 | 条目无相关文件。 | |||||
| 个性服务 |
| 推荐该条目 |
| 保存到收藏夹 |
| 导出为Endnote文件 |
| 谷歌学术 |
| 谷歌学术中相似的文章 |
| [Madame Claude Payri]的文章 |
| 百度学术 |
| 百度学术中相似的文章 |
| [Madame Claude Payri]的文章 |
| 必应学术 |
| 必应学术中相似的文章 |
| [Madame Claude Payri]的文章 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
